Evidence Paper Review

 Quick Explanation Copied

 Long Explanation

What the paper reports

A brief report from Hospital Universitario La Paz (Madrid) describes a 3-year-old girl with itchy, scaly, well-defined annular patches on the left medial knee, lower back, and upper thighs, progressing from pink macules first noted at 6 months of age. Over 2.5 years she received systemic and topical steroids, antihistamines, antifungals, antibiotics, and vitamins without improvement. Cultures, KOH, Gram stain, IgE, and a slit-skin smear for leprosy were negative; a skin biopsy showing a scabies mite egg in the epidermis established the diagnosis (Full case description and diagnostic workup). Permethrin 5% cream applied twice, two weeks apart, produced complete remission at one month.

Critical appraisal

• Diagnostic circularity risk: the annular morphology is atypical for scabies, and the causal link between the mite egg and the annular lesions rests on histology plus response to therapy, not on demonstration of live mites or burrows at the patch sites (Diagnostic basis and permethrin rationale).
• Missing details: no dermoscopy findings, no family/contact history reported, no long-term recurrence data, and no systematic exclusion of annular dermatoses (e.g., tinea was excluded by KOH, but granuloma annulare or annular psoriasis pathways are not fully addressed in the excerpt).
• Context on the delay: diagnostic uncertainty is common in scabies; a retrospective Australian cohort found 72.7% of inpatients prescribed scabicides had no documented diagnostic criteria (Scabies diagnostic uncertainty cohort study), and international guidelines emphasize microscopy/dermoscopy confirmation precisely to avoid such delays (Comprehensive scabies review, diagnostics and treatment).
• Treatment claim scope: cure after two permethrin applications is expected in typical scabies (~90% efficacy in reviews) (Permethrin first-line efficacy data), so the outcome supports but does not uniquely validate the diagnosis. Internal inconsistency: the case text says treatment was repeated two weeks apart while the discussion says one week later.

Bottom line and what would change it

The case is a credible, single-observer reminder that scabies can masquerade as annular dermatitis in young children and deserves inclusion when annular pruritic patches resist conventional therapy. Confidence is limited: n=1, no control, and possible publication bias favoring unusual presentations. Findings would change if biopsy-proven annular scabies failed permethrin or if larger series showed annular patches are unrelated to mite infestation.

 BGPT Paper Review

Study Novelty

Annular patch morphology is a genuinely uncommon scabies presentation; case reports of atypical scabies forms exist, but this specific phenotype adds a useful pattern to the differential for pediatric annular lesions.

Scientific Quality

Appropriate workup for the era (KOH, cultures, leprosy smear, biopsy) and clear outcome, but n=1, internal inconsistency on the repeat-treatment interval (1 vs 2 weeks), no dermoscopy, no family/contact history, and no follow-up for recurrence.

Study Generality

A single pediatric case with a rare phenotype; it widens the differential for annular pruritic patches but adds little generalizable knowledge beyond pattern recognition.

Study Usefulness

Practically useful as a diagnostic vigilance cue for clinicians managing chronic annular patches in children who fail steroids and antifungals; limited by absence of dermoscopy or recurrence data.

Study Reproducibility

Methods (biopsy, microscopy, permethrin regimen) are described, but single-case data, no imaging of microscopic findings beyond description, and inconsistent dosing interval hinder independent replication or comparison.

Explanatory Depth

Mechanistic explanation is thin: the paper does not explain why the mite produced annular morphology, nor report dermoscopic burrows; it relies on biopsy confirmation and therapeutic response.